Aktie 688639 ANHUI HUAHENG BIOTECHNOLOGY CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Anhui Huaheng Biotechnology Co., Ltd.

Aktien

688639

CNE1000052M6

688639

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 24.04.2024 		% 5 Tage % 1. Jan.
107,3 CNY +2,10 % Intraday Chart für Anhui Huaheng Biotechnology Co., Ltd. -0,75 % -14,77 %
22.04. Anhui Huaheng Biotechnology's Q1 Gewinn springt um 7% MT
22.04. Gewinn von Anhui Huaheng Biotechnology steigt 2023 um 40% MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Anhui Huaheng Biotechnology's Q1 Profit Jumps 7%
Anhui Huaheng Biotechnology's 2023 Profit Jumps 40%
Certain A Shares of Anhui Huaheng Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 22-APR-2024.
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Rate Cut Plans Boost China Stocks; Huaheng Biotechnology Jumps 9%
Huaheng Biotechnology to Set Up Subsidiary, Production Plant for 700 Million Yuan
Huaheng Biotechnology Gets Rights to Ouhe Biotechnology's Biological Arginine Production Technology
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback Plan announced on August 11, 2023.
Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback announced on August 11, 2023, has closed with 496,600 shares, representing 0.32% for CNY 49.98 million.
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tranche Update on Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback Plan announced on August 11, 2023.
Anhui Huaheng Biotechnology Co., Ltd.(XSSC:688639) added to S&P Global BMI Index
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has received CNY 20 million in funding from Anhui Huaheng Biotechnology Co., Ltd., Suzhou Kaifeng Zhengde Investment Management Co., Ltd.
Anhui Huaheng Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
Anhui Huaheng Biotechnology Co., Ltd. authorizes a Buyback Plan.
Anhui Huaheng Biotechnology Acquires Marketing Rights to Ouhe Biotechnology's Phytic Acid Technology
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 688639 Aktie
  4. Nachrichten Anhui Huaheng Biotechnology Co., Ltd.
  5. Andere Sprachen